Mingwei Li

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

K. Rhodes, S. Salloway, J. Sevigny, 2016, Nature.

Effect of combined treatment with methylprednisolone and soluble Nogo‐66 receptor after rat spinal cord injury

T. Engber, J. Relton, S. Strittmatter, 2005, The European journal of neuroscience.

Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

K. Rhodes, S. Salloway, J. Sevigny, 2017, Nature.

LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury

J. Relton, K. So, J. Mccoy, 2006, Molecular and Cellular Neuroscience.

Blockade of Nogo-66, Myelin-Associated Glycoprotein, and Oligodendrocyte Myelin Glycoprotein by Soluble Nogo-66 Receptor Promotes Axonal Sprouting and Recovery after Spinal Injury

J. Relton, S. Strittmatter, S. Rabacchi, 2004, The Journal of Neuroscience.

Molecular characterization and preclinical efficacy

T. Engber, P. Weinreb, J. Grimm, 2011, Alzheimer's & Dementia.